EXPLORING SOCIAL DETERMINANT OF HEALTH AND WATCHMAN DEVICE USE IN END-STAGE RENAL DISEASE PATIENTS WITH ATRIAL FIBRILLATION

被引：0
|
作者：
Sherafati, Alborz [1 ]
Canova, Tyler [1 ]
Issa, Rochell [1 ]
Baxter, Patrick [1 ]
Koizumi, Naoru [1 ]
Eltahawy, Ehab Ahmed [1 ]
Ekwenna, Obi [1 ]
机构：
[1] Univ Toledo, Toledo, OH USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1249-176
引用
收藏
页码：945 / 945
页数：1
相关论文
共 50 条
  • [21] Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned
    Benz, Alexander P. P.
    Eikelboom, John W. W.
    [J]. CIRCULATION, 2022, 146 (23) : 1746 - 1748
  • [22] Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 351 - 352
  • [23] AMPLIFICATION OF INFLAMMATORY AND HEMOSTATIC DYSREGULATION RESPONSES IN ATRIAL FIBRILLATION PATIENTS WITH END-STAGE RENAL DISEASE
    Abrenica, Alyssandra
    Tahar, Meriam Ben Hadj
    Bontekoe, Emily
    Hoppensteadt, Debra A.
    Syed, Mushabbar A.
    Bansal, Vinod
    Fareed, Jawed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 351 - 351
  • [24] Risk profiles for acute health events after incident atrial fibrillation in patients With end-stage renal disease on hemodialysis
    Airy, Medha
    Chang, Tara, I
    Ding, Victoria Y.
    Goldstein, Benjamin A.
    Bansal, Nisha
    Niu, Jingbo
    Navaneethan, Sankar D.
    Turakhia, Mintu P.
    Winkelmayer, Wolfgang C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (09) : 1590 - 1597
  • [25] Outcomes Associated With Rivaroxaban in Asians With End-stage Renal Disease and Atrial Fibrillation
    Lin, Yi-Cheng
    Chien, Li-Nien
    Chen, Liying
    Chen, Bi-Li
    Fang, Te-Chao
    Huang, Chun-Yao
    [J]. CIRCULATION, 2019, 140
  • [26] Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
    Suwanwongse, Kulachanya
    Shabarek, Nehad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [27] Stroke and Bleeding in Patients with Atrial Fibrillation and End-Stage Renal Disease Treated with Apixaban Versus Warfarin
    Lara, Joao Manoel Da Silveira
    Dourado, Claudia
    [J]. BLOOD, 2023, 142
  • [28] EVALUATION OF P WAVE INDICES AND A NOVEL PREDICTOR OF ATRIAL FIBRILLATION IN PATIENTS WITH END-STAGE RENAL DISEASE
    Solak, Y.
    Gul, E. E.
    Abdulhalikov, T.
    Atalay, H.
    Kayrak, M.
    Turk, S.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S52 - S52
  • [29] Atrial Fibrillation and Anticoagulant Treatment in End-Stage Renal Disease Patients: Where Do We Stand?
    Di Lullo, Luca
    Mariani, Marco Valerio
    Ronco, Claudio
    Bellasi, Antonio
    Lavalle, Carlo
    Chimenti, Cristina
    Paoletti, Ernesto
    Ravera, Maura
    Zanella, Monica
    [J]. CARDIORENAL MEDICINE, 2022, 12 (04) : 131 - 140
  • [30] Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
    Yalamanchili, Venkata
    Reilly, Robert F.
    [J]. SEMINARS IN DIALYSIS, 2011, 24 (04) : 387 - 388
12345